☆Vestal Point Capital, LP
Quality Q
0.263
AUM ($M)
4,279
Positions
68
Turnover
0.38
Top-10 wt
50%
Herfindahl
0.036
History (qtrs)
6
Excess Return
—
AI Eval Run AI Eval
Holdings · 101 positions · portfolio value $4,279M
| Ticker | Name | Activity | Security Type | Weight | Δ Weight | Value ($M) | Shares | Δ Shares | Qtrs Held | Excess Return |
|---|---|---|---|---|---|---|---|---|---|---|
| ☆BMRN funds › | BioMarin Pharmaceutical Inc | ADD | — | 8.1% | +2.4% | 344.8 | 6,025,000 | +2,450,000 | 5 | — |
| ☆NBIX funds › | Neurocrine Biosciences Inc | ADD | — | 7.4% | +2.8% | 316.8 | 1,880,000 | +630,000 | 2 | — |
| ☆ABVX funds › | Abivax SA | ADD | — | 7.3% | +2.6% | 313.1 | 2,349,443 | +849,443 | 4 | — |
| ☆UTHR funds › | United Therapeutics Corp | ADD | — | 5.5% | +4.3% | 235.7 | 435,000 | +360,000 | 2 | — |
| ☆ELVN funds › | Enliven Therapeutics Inc | ADD | — | 4.7% | +1.2% | 203.0 | 4,000,000 | +750,000 | 5 | — |
| ☆NRIX funds › | Nurix Therapeutics Inc | ADD | — | 4.6% | +1.7% | 195.3 | 8,050,000 | +1,550,000 | 5 | — |
| ☆BCAX funds › | Bicara Therapeutics Inc | TRIM | — | 3.6% | +0.6% | 155.9 | 5,250,000 | -175,000 | 5 | — |
| ☆TSHA funds › | Taysha Gene Therapies Inc | ADD | — | 3.1% | +0.8% | 132.2 | 19,415,000 | +1,415,000 | 5 | — |
| ☆ARWR funds › | Arrowhead Pharmaceuticals Inc | TRIM | — | 3.0% | -1.0% | 128.4 | 1,575,000 | -700,000 | 3 | — |
| ☆ABT funds › | Abbott Laboratories | NEW | — | 3.0% | +3.0% | 127.0 | 1,400,000 | +1,400,000 | 1 | — |
| ☆ZBH funds › | Zimmer Biomet Holdings Inc | ADD | — | 2.8% | +2.3% | 120.5 | 1,400,000 | +1,210,000 | 3 | — |
| ☆IRON funds › | Disc Medicine Inc | ADD | — | 2.6% | +1.4% | 113.4 | 1,550,000 | +850,000 | 5 | — |
| ☆GLUE funds › | Monte Rosa Therapeutics Inc | ADD | — | 2.6% | +0.9% | 111.3 | 4,600,000 | +996,535 | 4 | — |
| ☆PODD funds › | Insulet Corp | ADD | — | 2.4% | +2.1% | 102.0 | 670,000 | +619,399 | 2 | — |
| ☆ASND funds › | Ascendis Pharma A/S | NEW | — | 2.3% | +2.3% | 100.0 | 375,000 | +375,000 | 1 | — |
| ☆AZN funds › | AstraZeneca PLC | ADD | — | 2.0% | +1.4% | 85.3 | 450,000 | +350,000 | 2 | — |
| ☆SNY funds › | Sanofi SA | ADD | — | 2.0% | +0.1% | 85.3 | 2,000,000 | +600,000 | 2 | — |
| ☆RVMD funds › | Revolution Medicines Inc | TRIM | — | 2.0% | -4.5% | 84.3 | 450,000 | -1,925,000 | 5 | — |
| ☆BCRX funds › | BioCryst Pharmaceuticals Inc | ADD | — | 1.9% | +0.1% | 83.0 | 8,300,000 | +1,275,000 | 3 | — |
| ☆DYN funds › | Dyne Therapeutics Inc | TRIM | — | 1.8% | -0.3% | 75.0 | 3,375,000 | -625,000 | 5 | — |
| ☆NKTR funds › | Nektar Therapeutics | ADD | — | 1.6% | +1.1% | 69.8 | 1,000,000 | +715,000 | 2 | — |
| ☆GMED funds › | Globus Medical Inc | ADD | — | 1.6% | +0.1% | 67.2 | 850,000 | +239,480 | 5 | — |
| ☆TARS funds › | Tarsus Pharmaceuticals Inc | ADD | — | 1.5% | +1.2% | 66.1 | 1,050,000 | +850,000 | 2 | — |
| ☆IMTX funds › | Immatics NV | HOLD | — | 1.5% | -0.2% | 62.6 | 6,175,000 | +0 | 5 | — |
| ☆TRVI funds › | Trevi Therapeutics Inc | ADD | — | 1.4% | +0.6% | 57.8 | 3,100,000 | +933,496 | 2 | — |
| ☆IMCR funds › | Immunocore Holdings PLC | TRIM | — | 1.3% | -1.0% | 57.1 | 1,800,000 | -966,868 | 3 | — |
| ☆RGEN funds › | Repligen Corp | TRIM | — | 1.3% | -1.8% | 54.6 | 400,000 | -525,000 | 4 | — |
| ☆BMY funds › | Bristol-Myers Squibb Co | TRIM | — | 1.1% | -0.6% | 46.1 | 800,000 | -200,000 | 3 | — |
| ☆QURE funds › | uniQure NV | ADD | — | 1.0% | +0.8% | 43.1 | 935,000 | +576,004 | 2 | — |
| ☆XENE funds › | Xenon Pharmaceuticals Inc | ADD | — | 1.0% | -0.1% | 42.3 | 700,000 | +60,100 | 5 | — |
| ☆DRUG funds › | Bright Minds Biosciences Inc | ADD | — | 0.9% | -0.1% | 38.3 | 545,000 | +52,681 | 2 | — |
| ☆MDGL funds › | Madrigal Pharmaceuticals Inc | ADD | — | 0.8% | +0.4% | 34.9 | 65,000 | +33,532 | 2 | — |
| ☆ALC funds › | Alcon AG | TRIM | — | 0.8% | -0.9% | 33.5 | 500,000 | -300,000 | 5 | — |
| ☆MYGN funds › | Myriad Genetics Inc | ADD | — | 0.8% | +0.6% | 32.7 | 5,735,000 | +4,087,000 | 4 | — |
| ☆RAPP funds › | Rapport Therapeutics Inc | TRIM | — | 0.7% | -0.5% | 30.4 | 730,000 | -706,229 | 4 | — |
| ☆CBIO funds › | Crescent Biopharma Inc | ADD | — | 0.7% | -0.1% | 29.3 | 1,630,000 | +130,000 | 3 | — |
| ☆GEHC funds › | GE HealthCare Technologies Inc | ADD | — | 0.7% | +0.2% | 28.8 | 450,000 | +200,000 | 2 | — |
| ☆INSM funds › | Insmed Inc | NEW | — | 0.6% | +0.6% | 26.7 | 250,000 | +250,000 | 1 | — |
| ☆VKTX funds › | Viking Therapeutics Inc | TRIM | — | 0.6% | -0.2% | 26.5 | 680,000 | -234,147 | 2 | — |
| ☆BBNX funds › | Beta Bionics Inc | TRIM | — | 0.6% | -0.0% | 25.1 | 1,600,000 | -611,518 | 5 | — |
| ☆REGN funds › | Regeneron Pharmaceuticals Inc | HOLD | — | 0.6% | -0.3% | 24.9 | 40,000 | +0 | 2 | — |
| ☆SLDB funds › | Solid Biosciences Inc | TRIM | — | 0.5% | -0.5% | 21.6 | 2,160,000 | -2,840,000 | 5 | — |
| ☆ANRO funds › | Alto Neuroscience Inc | TRIM | — | 0.5% | -0.8% | 20.7 | 785,000 | -1,279,075 | 5 | — |
| ☆TRAX funds › | First Tracks Biotherapeutics I | NEW | — | 0.5% | +0.5% | 20.4 | 1,013,000 | +1,013,000 | 1 | — |
| ☆LXEO funds › | Lexeo Therapeutics Inc | TRIM | — | 0.5% | -0.2% | 20.1 | 4,320,000 | -155,000 | 5 | — |
| ☆SVRA funds › | Savara Inc | ADD | — | 0.4% | -0.0% | 16.8 | 2,720,000 | +119,948 | 5 | — |
| ☆DMRA funds › | Damora Therapeutics Inc | TRIM | — | 0.3% | -0.1% | 15.0 | 575,000 | -25,000 | 2 | — |
| ☆SGP funds › | SpyGlass Pharma Inc | ADD | — | 0.3% | -0.1% | 14.9 | 670,000 | +3,240 | 2 | — |
| ☆TECX funds › | Tectonic Therapeutic Inc | ADD | — | 0.3% | +0.1% | 14.6 | 425,000 | +97,000 | 3 | — |
| ☆AVTX funds › | Avalo Therapeutics Inc | NEW | — | 0.3% | +0.3% | 14.3 | 775,000 | +775,000 | 1 | — |
| ☆EVMN funds › | Evommune Inc | NEW | — | 0.3% | +0.3% | 13.3 | 1,000,000 | +1,000,000 | 1 | — |
| ☆KLRA funds › | Kailera Therapeutics Inc | NEW | — | 0.3% | +0.3% | 12.7 | 575,000 | +575,000 | 1 | — |
| ☆AVR funds › | Anteris Technologies Global Co | TRIM | — | 0.2% | +0.1% | 9.9 | 1,010,000 | -134,780 | 2 | — |
| ☆ZBIO funds › | Zenas Biopharma Inc | ADD | — | 0.2% | +0.1% | 9.3 | 365,000 | +165,000 | 2 | — |
| ☆VYGR funds › | Voyager Therapeutics Inc | TRIM | — | 0.2% | -0.1% | 9.2 | 2,625,000 | -377,936 | 5 | — |
| ☆OKUR funds › | OnKure Therapeutics Inc | TRIM | — | 0.2% | -0.0% | 8.3 | 1,825,699 | -14,120 | 5 | — |
| ☆SRZN funds › | Surrozen Inc | TRIM | — | 0.2% | -0.1% | 7.9 | 304,669 | -33,942 | 2 | — |
| ☆MNPR funds › | Monopar Therapeutics Inc | ADD | — | 0.2% | +0.1% | 7.0 | 75,727 | +10,309 | 2 | — |
| ☆ZURA funds › | Zura Bio Ltd | ADD | — | 0.2% | +0.1% | 6.9 | 1,173,956 | +662,956 | 2 | — |
| ☆OLMA funds › | Olema Pharmaceuticals Inc | TRIM | — | 0.1% | -0.1% | 5.2 | 418,551 | -10,000 | 3 | — |
| ☆PALI funds › | Palisade Bio Inc | HOLD | — | 0.1% | -0.0% | 5.2 | 2,500,000 | +0 | 2 | — |
| ☆IBIO funds › | iBio Inc | NEW | — | 0.1% | +0.1% | 4.5 | 2,600,000 | +2,600,000 | 1 | — |
| ☆SGMT funds › | Sagimet Biosciences Inc | NEW | — | 0.1% | +0.1% | 4.1 | 535,452 | +535,452 | 1 | — |
| ☆ENGN funds › | enGene Therapeutics Inc | NEW | — | 0.1% | +0.1% | 2.9 | 1,667,430 | +1,667,430 | 1 | — |
| ☆RZLT funds › | Rezolute Inc | NEW | — | 0.0% | +0.0% | 2.0 | 382,999 | +382,999 | 1 | — |
| ☆NYXH funds › | Nyxoah SA | TRIM | — | 0.0% | -0.0% | 1.4 | 843,461 | -25,200 | 5 | — |
| ☆TENX funds › | Tenax Therapeutics Inc | HOLD | — | 0.0% | -0.0% | 0.8 | 53,439 | +0 | 5 | — |
| ☆APRE funds › | Aprea Therapeutics Inc | HOLD | — | 0.0% | -0.0% | 0.3 | 350,000 | +0 | 2 | — |
| ☆AGIO funds › | Agios Pharmaceuticals Inc | EXIT | — | 0.0% | -0.4% | 0.0 | 0 | -450,000 | 0 | — |
| ☆SRRK funds › | Scholar Rock Holding Corp | EXIT | — | 0.0% | -1.8% | 0.0 | 0 | -1,324,422 | 0 | — |
| ☆COGT funds › | Cogent Biosciences Inc | EXIT | — | 0.0% | -1.3% | 0.0 | 0 | -1,230,888 | 0 | — |
| ☆APGE funds › | Apogee Therapeutics Inc | EXIT | — | 0.0% | -2.6% | 0.0 | 0 | -1,100,000 | 0 | — |
| ☆CADL funds › | Candel Therapeutics Inc | EXIT | — | 0.0% | -0.2% | 0.0 | 0 | -1,125,000 | 0 | — |
| ☆CYTK funds › | Cytokinetics Inc | EXIT | — | 0.0% | -0.6% | 0.0 | 0 | -300,000 | 0 | — |
| ☆VERA funds › | Vera Therapeutics Inc | EXIT | — | 0.0% | -1.5% | 0.0 | 0 | -1,368,159 | 0 | — |
| ☆WGS funds › | GeneDx Holdings Corp | EXIT | — | 0.0% | -0.4% | 0.0 | 0 | -250,000 | 0 | — |
| ☆BSX funds › | Boston Scientific Corp | EXIT | — | 0.0% | -1.4% | 0.0 | 0 | -800,000 | 0 | — |
| ☆CLDX funds › | Celldex Therapeutics Inc | EXIT | — | 0.0% | -1.1% | 0.0 | 0 | -1,224,165 | 0 | — |
| ☆DNLI funds › | Denali Therapeutics Inc | EXIT | — | 0.0% | -1.0% | 0.0 | 0 | -1,773,326 | 0 | — |
| ☆INSP funds › | Inspire Medical Systems Inc | EXIT | — | 0.0% | -0.8% | 0.0 | 0 | -539,269 | 0 | — |
| ☆FULC funds › | Fulcrum Therapeutics Inc | EXIT | — | 0.0% | -0.2% | 0.0 | 0 | -1,100,000 | 0 | — |
| ☆CUSIP:29286M105 funds › | enGene Therapeutics Inc | EXIT | — | 0.0% | -0.4% | 0.0 | 0 | -2,165,000 | 0 | — |
| ☆ARVN funds › | Arvinas Inc | EXIT | — | 0.0% | -0.3% | 0.0 | 0 | -905,465 | 0 | — |
| ☆PTGX funds › | Protagonist Therapeutics Inc | EXIT | — | 0.0% | -1.0% | 0.0 | 0 | -326,159 | 0 | — |
| ☆TYRA funds › | Tyra Biosciences Inc | EXIT | — | 0.0% | -0.1% | 0.0 | 0 | -54,000 | 0 | — |
| ☆URGN funds › | UroGen Pharma Ltd | EXIT | — | 0.0% | -0.1% | 0.0 | 0 | -139,079 | 0 | — |
| ☆WAT funds › | Waters Corp | EXIT | — | 0.0% | -0.8% | 0.0 | 0 | -100,000 | 0 | — |
| ☆PASG funds › | Passage Bio Inc | EXIT | — | 0.0% | -0.1% | 0.0 | 0 | -305,000 | 0 | — |
| ☆WST funds › | West Pharmaceutical Services I | EXIT | — | 0.0% | -0.5% | 0.0 | 0 | -75,000 | 0 | — |
| ☆ABSI funds › | Absci Corp | EXIT | Common Stock | 0.0% | -0.0% | 0.0 | 0 | -232,219 | 0 | — |
| ☆NUVL funds › | Nuvalent Inc | EXIT | — | 0.0% | -1.4% | 0.0 | 0 | -481,715 | 0 | — |
| ☆CUSIP:483497103 funds › | KalVista Pharmaceuticals Inc | EXIT | — | 0.0% | -1.0% | 0.0 | 0 | -1,850,000 | 0 | — |
| ☆MGNX funds › | MacroGenics Inc | EXIT | — | 0.0% | -0.0% | 0.0 | 0 | -280,000 | 0 | — |
| ☆CUSIP:834203309 funds › | Soleno Therapeutics Inc | EXIT | — | 0.0% | -0.7% | 0.0 | 0 | -730,000 | 0 | — |
| ☆CUSIP:880881107 funds › | Terns Pharmaceuticals Inc | EXIT | — | 0.0% | -1.5% | 0.0 | 0 | -1,000,000 | 0 | — |
| ☆MPLT funds › | MapLight Therapeutics Inc | EXIT | — | 0.0% | -0.2% | 0.0 | 0 | -420,000 | 0 | — |
| ☆VCYT funds › | Veracyte Inc | EXIT | — | 0.0% | -0.1% | 0.0 | 0 | -130,687 | 0 | — |
| ☆NVCR funds › | Novocure Ltd | EXIT | — | 0.0% | -0.1% | 0.0 | 0 | -250,000 | 0 | — |
| ☆RGNX funds › | REGENXBIO Inc | EXIT | — | 0.0% | -0.0% | 0.0 | 0 | -108,525 | 0 | — |
| ☆CUSIP:04351P101 funds › | Ascendis Pharma A/S | EXIT | — | 0.0% | -2.4% | 0.0 | 0 | -375,000 | 0 | — |
| ☆GERN funds › | Geron Corp | EXIT | — | 0.0% | -0.1% | 0.0 | 0 | -2,540,000 | 0 | — |
Point-in-time history
| Period | AUM ($M) | Positions | Turnover | Top-10 wt | Herfindahl | Quality Q | Skill | Universe |
|---|---|---|---|---|---|---|---|---|
| 2026Q2 | 4,279 | 68 | 0.38 | 50% | 0.036 | 0.261 | — | in |
| 2026Q1 | 3,577 | 90 | 0.49 | 40% | 0.026 | 0.087 | — | in |
| 2025Q4 | 2,726 | 75 | 0.49 | 49% | 0.036 | 0.079 | — | in |
| 2025Q3 | 2,204 | 80 | 0.41 | 39% | 0.024 | 0.091 | — | in |
| 2025Q2 | 1,899 | 72 | 0.33 | 45% | 0.033 | 0.223 | — | entered |
| 2025Q1 | 1,400 | 63 | 0.00 | 51% | 0.040 | 0.000 | — | out |
Long US-equity 13F disclosures only · up to 45-day reporting lag · sells = reduce/avoid, not short.
JSON: /api/signals ·
/api/funds ·
/api/status